783 related articles for article (PubMed ID: 25693567)
1. Cell-of-origin chromatin organization shapes the mutational landscape of cancer.
Polak P; Karlić R; Koren A; Thurman R; Sandstrom R; Lawrence M; Reynolds A; Rynes E; Vlahoviček K; Stamatoyannopoulos JA; Sunyaev SR
Nature; 2015 Feb; 518(7539):360-364. PubMed ID: 25693567
[TBL] [Abstract][Full Text] [Related]
2. Mutation Signatures Depend on Epigenomic Contexts.
Coleman N; De S
Trends Cancer; 2018 Oct; 4(10):659-661. PubMed ID: 30292349
[TBL] [Abstract][Full Text] [Related]
3. Mutalisk: a web-based somatic MUTation AnaLyIS toolKit for genomic, transcriptional and epigenomic signatures.
Lee J; Lee AJ; Lee JK; Park J; Kwon Y; Park S; Chun H; Ju YS; Hong D
Nucleic Acids Res; 2018 Jul; 46(W1):W102-W108. PubMed ID: 29790943
[TBL] [Abstract][Full Text] [Related]
4. Epigenomics: Roadmap for regulation.
Romanoski CE; Glass CK; Stunnenberg HG; Wilson L; Almouzni G
Nature; 2015 Feb; 518(7539):314-6. PubMed ID: 25693562
[No Abstract] [Full Text] [Related]
5. Explaining cancer type specific mutations with transcriptomic and epigenomic features in normal tissues.
Tiong KL; Yeang CH
Sci Rep; 2018 Jul; 8(1):11456. PubMed ID: 30061703
[TBL] [Abstract][Full Text] [Related]
6. Chromatin accessibility of primary human cancers ties regional mutational processes and signatures with tissues of origin.
Ocsenas O; Reimand J
PLoS Comput Biol; 2022 Aug; 18(8):e1010393. PubMed ID: 35947558
[TBL] [Abstract][Full Text] [Related]
7. Regional mutational signature activities in cancer genomes.
Timmons C; Morris Q; Harrigan CF
PLoS Comput Biol; 2022 Dec; 18(12):e1010733. PubMed ID: 36469539
[TBL] [Abstract][Full Text] [Related]
8. Epigenomic Consequences of Coding and Noncoding Driver Mutations.
Yao X; Xing M; Ooi WF; Tan P; Teh BT
Trends Cancer; 2016 Oct; 2(10):585-605. PubMed ID: 28741489
[TBL] [Abstract][Full Text] [Related]
9. Local Determinants of the Mutational Landscape of the Human Genome.
Gonzalez-Perez A; Sabarinathan R; Lopez-Bigas N
Cell; 2019 Mar; 177(1):101-114. PubMed ID: 30901533
[TBL] [Abstract][Full Text] [Related]
10. Epigenomic landscape of melanoma progression to brain metastasis: unexplored therapeutic alternatives.
Marzese DM; Witz IP; Kelly DF; Hoon DS
Epigenomics; 2015; 7(8):1303-11. PubMed ID: 26638944
[TBL] [Abstract][Full Text] [Related]
11. Mutational signature SBS8 predominantly arises due to late replication errors in cancer.
Singh VK; Rastogi A; Hu X; Wang Y; De S
Commun Biol; 2020 Aug; 3(1):421. PubMed ID: 32747711
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of cancer breakpoints reveals signatures of genetic and epigenetic contribution to cancer genome rearrangements.
Cheloshkina K; Poptsova M
PLoS Comput Biol; 2021 Mar; 17(3):e1008749. PubMed ID: 33647036
[TBL] [Abstract][Full Text] [Related]
13. Integrative analysis of 111 reference human epigenomes.
; Kundaje A; Meuleman W; Ernst J; Bilenky M; Yen A; Heravi-Moussavi A; Kheradpour P; Zhang Z; Wang J; Ziller MJ; Amin V; Whitaker JW; Schultz MD; Ward LD; Sarkar A; Quon G; Sandstrom RS; Eaton ML; Wu YC; Pfenning AR; Wang X; Claussnitzer M; Liu Y; Coarfa C; Harris RA; Shoresh N; Epstein CB; Gjoneska E; Leung D; Xie W; Hawkins RD; Lister R; Hong C; Gascard P; Mungall AJ; Moore R; Chuah E; Tam A; Canfield TK; Hansen RS; Kaul R; Sabo PJ; Bansal MS; Carles A; Dixon JR; Farh KH; Feizi S; Karlic R; Kim AR; Kulkarni A; Li D; Lowdon R; Elliott G; Mercer TR; Neph SJ; Onuchic V; Polak P; Rajagopal N; Ray P; Sallari RC; Siebenthall KT; Sinnott-Armstrong NA; Stevens M; Thurman RE; Wu J; Zhang B; Zhou X; Beaudet AE; Boyer LA; De Jager PL; Farnham PJ; Fisher SJ; Haussler D; Jones SJ; Li W; Marra MA; McManus MT; Sunyaev S; Thomson JA; Tlsty TD; Tsai LH; Wang W; Waterland RA; Zhang MQ; Chadwick LH; Bernstein BE; Costello JF; Ecker JR; Hirst M; Meissner A; Milosavljevic A; Ren B; Stamatoyannopoulos JA; Wang T; Kellis M
Nature; 2015 Feb; 518(7539):317-30. PubMed ID: 25693563
[TBL] [Abstract][Full Text] [Related]
14. A site specific model and analysis of the neutral somatic mutation rate in whole-genome cancer data.
Bertl J; Guo Q; Juul M; Besenbacher S; Nielsen MM; Hornshøj H; Pedersen JS; Hobolth A
BMC Bioinformatics; 2018 Apr; 19(1):147. PubMed ID: 29673314
[TBL] [Abstract][Full Text] [Related]
15. An evolutionary framework for measuring epigenomic information and estimating cell-type-specific fitness consequences.
Gulko B; Siepel A
Nat Genet; 2019 Feb; 51(2):335-342. PubMed ID: 30559490
[TBL] [Abstract][Full Text] [Related]
16. Chromatin accessibility contributes to simultaneous mutations of cancer genes.
Shi Y; Su XB; He KY; Wu BH; Zhang BY; Han ZG
Sci Rep; 2016 Oct; 6():35270. PubMed ID: 27762310
[TBL] [Abstract][Full Text] [Related]
17. Chromatin organization is a major influence on regional mutation rates in human cancer cells.
Schuster-Böckler B; Lehner B
Nature; 2012 Aug; 488(7412):504-7. PubMed ID: 22820252
[TBL] [Abstract][Full Text] [Related]
18. Somatic mutation distributions in cancer genomes vary with three-dimensional chromatin structure.
Akdemir KC; Le VT; Kim JM; Killcoyne S; King DA; Lin YP; Tian Y; Inoue A; Amin SB; Robinson FS; Nimmakayalu M; Herrera RE; Lynn EJ; Chan K; Seth S; Klimczak LJ; Gerstung M; Gordenin DA; O'Brien J; Li L; Deribe YL; Verhaak RG; Campbell PJ; Fitzgerald R; Morrison AJ; Dixon JR; Andrew Futreal P
Nat Genet; 2020 Nov; 52(11):1178-1188. PubMed ID: 33020667
[TBL] [Abstract][Full Text] [Related]
19. Chromatin modifications and genomic contexts linked to dynamic DNA methylation patterns across human cell types.
Yan H; Zhang D; Liu H; Wei Y; Lv J; Wang F; Zhang C; Wu Q; Su J; Zhang Y
Sci Rep; 2015 Feb; 5():8410. PubMed ID: 25673498
[TBL] [Abstract][Full Text] [Related]
20. Epigenomics in 3D: importance of long-range spreading and specific interactions in epigenomic maintenance.
Jost D; Vaillant C
Nucleic Acids Res; 2018 Mar; 46(5):2252-2264. PubMed ID: 29365171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
